Recurrent cases are 60% of DKA
hospitalizations.
by Jancin, Bruce
KEYSTONE, COLO. -- If it seems like the same handful of patients in
your practice are hospitalized again and again for diabetic
ketoacidosis, you're not imagining things, Dr. Robert Slover said
at a conference on the management of diabetes in youth.
A prospective 2002 study of 1,243 Denver-area children and teens
with type 1 diabetes followed for an average of 3.2 years showed that
60% of all hospitalizations for diabetic ketoacidosis (DKA) in patients
with established diabetes occurred in the 5% of youths who had two or
more DKA events.
"In other words, we see the same kids over and over and over
again. Unfortunately, that's the pattern across the United States
and worldwide. A few patients make up the majority of the problem of DKA
in patients with known diabetes," said Dr. Slover, a pediatric
endocrinologist at the Barbara Davis Center for Childhood Diabetes,
Aurora, Colo.
The overall incidence of DKA in the Denver study was eight cases
per 100 person-years. Among patients with established diabetes who were
aged 7-12 or 13-19, the rate was significantly higher in girls than
boys, while in patients younger than 7 years the opposite was true (JAMA
2002;287:2511-18).
In addition to prior DKA episodes and female sex, this study and
others have identified other risk factors for DKA in children with
established type 1 diabetes. These include lower socioeconomic status,
lack of appropriate health insurance, poor metabolic control, eating
disorders or other psychiatric conditions, and inappropriate
interruption of insulin pump therapy.
DKA is a huge problem. It causes 160,000 admissions to private
hospitals annually. The cost of care is in excess of $1 billion per
year. Patients younger than 19 years old account for 65% of cases, and
DKA is far and away the leading cause of diabetes-related death in
children, accounting for 85% of cases.
Cerebral edema is the cause of 69%-80% of DKA-related deaths, said
Dr. Slover. "That figure ought to be 100%," he said,
"because the other causes of mortality in children with DKA we
really ought to be able to prevent: hypokalemia, hyperkalemia,
thrombosis, sepsis, intracranial bleeding, aspiration pneumonia."
Cerebral edema in patients with DKA has a high morbidity and
mortality. Overall, 20% of those with cerebral edema die, and another
20% are left with mild to severe neurologic impairment.
[ILLUSTRATION OMITTED]
A 95-patient study of the timing of onset of cerebral edema in DKA
showed that while the peak onset was 3.0-5.9 hours into treatment, there
were as many cases with onset at hours 12-15 as during the first 3
hours. In a few cases, onset occurred as late as hours 18-24, according
to the study, conducted at the University of Florida, Gainesville
(Diabetes Care 2004;27:1541-6).
"That's important to recognize," Dr. Slover
stressed. "These children can develop cerebral edema once they are
resolving--when their pH is coming up, their blood glucose is looking
better, and they seem to be doing pretty well."
Patients with DKA who are at increased risk of cerebral edema
include those who have prolonged severe acidosis with an initial pH of
less than 7.1, have abnormal baseline mental status, are aged younger
than 5 years, have hypernatremia or persistent hyponatremia, or undergo
rapid rehydration in excess of about 50 cc/kg in the first 4 hours.
Signs and symptoms of pending cerebral edema include a sudden
return of vomiting, worsening level of consciousness, rise in blood
pressure, bradycardia, and headache.
Don't send a patient with suspected cerebral edema off for
confirmatory CT or MRI, Dr. Slover urged. Instead, treat presumptively.
Brain imaging changes are often not apparent early on.
The meeting was sponsored by the Barbara Davis Center for Diabetes,
the University of Colorado, and the Children's Diabetes Foundation
at Denver.
BY BRUCE JANCIN
Denver Bureau
COPYRIGHT 2008 International Medical News
Group Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.